HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toll-like receptor 3 agonist Poly I:C protects against simulated cerebral ischemia in vitro and in vivo.

AbstractAIM:
To examine the neuroprotective effects of the Toll-like receptor 3 (TLR3) agonist Poly I:C in acute ischemic models in vitro and in vivo.
METHODS:
Primary astrocyte cultures subjected to oxygen-glucose deprivation (OGD) were used as an in vitro simulated ischemic model. Poly I:C was administrated 2 h before OGD. Cell toxicity was measured using MTT assay and LDH leakage assay. The levels of TNFα, IL-6 and interferon-β (IFNβ) in the media were measured using ELISA. Toll/interleukin receptor domain-containing adaptor-inducing IFNβ (TRIF) protein levels were detected using Western blot analysis. A mouse middle cerebral artery occlusion (MCAO) model was u sed for in vivo study. The animals were administered Poly I:C (0.3 mg/kg, im) 2 h before MCAO, and examined with neurological deficit scoring and TTC staining. The levels of TNFα and IL-6 in ischemic brain were measured using ELISA.
RESULTS:
Pretreatment with Poly I:C (10 and 20 μg/mL) markedly attenuated OGD-induced astrocyte injury, and significantly raised the cell viability and reduced the LDH leakage. Poly I:C significantly upregulated TRIF expression accompanied by increased downstream IFNβ production. Moreover, Poly I:C significantly suppressed the pro-inflammatory cytokines TNFα and IL-6 production. In mice subjected to MCAO, administration of Poly I:C significantly attenuated the neurological deficits, reduced infarction volume, and suppressed the increased levels of TNFα and IL-6 in the ischemic striatum and cortex.
CONCLUSION:
Poly I:C pretreatment exerts neuroprotective and anti-inflammatory effects in the simulated cerebral ischemia models, and the neuroprotection is at least in part due to the activation of the TLR3-TRIF pathway.
AuthorsLin-na Pan, Wei Zhu, Cai Li, Xu-lin Xu, Lian-jun Guo, Qing Lu
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 33 Issue 10 Pg. 1246-53 (Oct 2012) ISSN: 1745-7254 [Electronic] United States
PMID22983393 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Culture Media
  • Neuroprotective Agents
  • Toll-Like Receptor 3
  • Glucose
  • Poly I-C
  • Oxygen
Topics
  • Animals
  • Astrocytes (drug effects, metabolism)
  • Blotting, Western
  • Cell Culture Techniques
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Culture Media
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Glucose (metabolism)
  • Ischemic Attack, Transient (metabolism, prevention & control)
  • Mice
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Oxygen (metabolism)
  • Poly I-C (pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Toll-Like Receptor 3 (agonists)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: